SEC Form 4 · accession 0001144204-17-008751

BIOHITECH GLOBAL, INC. · BHTG

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Executive Officer · Director · 10% Owner

Period of report

Feb 13, 2017

Accepted (ET)

Feb 14, 2017 · 3:46 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001590383

Table I — non-derivative securities

No Table I lines on this filing.

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Convertible Promissory Note^F3,F1,F2	$2.75	Feb 13, 2017	X	1	A	Feb 13, 2017	Feb 13, 2019	Common Stock	72,727	1	D
Warrants^F5,F3,F4	$3.30	Feb 13, 2017	X	72,727	A	Feb 13, 2017	Feb 13, 2022	Common Stock	72,727	72,727	D

F1Represents the highest possible conversion price of the note.
F2Represents the number of shares of common stock, par value $0.001 per share (the "Common Stock") into which the note is convertible based on the conversion price of $2.75 per share. The note is convertible into an indeterminable number of shares.
F3Does not include: 1,293,685 shares of common stock held by the reporting person; 506,667 shares of common stock underlying convertible debentures in the principal amount of $1,900,000 at the highest possible conversion price of $3.75 per share; 90,909 shares of common stock underlying convertible debentures in the principal amount of $250,000 at the highest possible conversion price of $2.75 per share or warrants to purchase an additional 597,576 shares of common stock held by the reporting person. The notes and warrants are currently convertible into an indeterminable number of shares of common stock.
F4Based upon 120% of the conversion price of $2.75 per share. The warrants are exercisable into an indeterminable number of shares.
F5Represents the number of shares of Common Stock into which the warrants are exercisable based on the exercise price of $3.30 per share.